Impact Factor: 7.883
Submit Paper
Volume 9, Issue 12 (December 2023)

Review On Novel Anticancer Agent Of Dostarlimab

Impact Factor
7.883
Call For Paper
Volume 12 Issue 07

July 2026

Download Paper Format
Copyright Form
Share on:

Author(s)

S. Naveenkumar N. Ramanathan

Abstract

One Of The Most Deadly Illnesses Of The 20th Century, Cancer Has Alarmingly Increased In The 21st, To The Point Where It Now Affects Every 4 People. Accordimg To GLOBOCAN 2020, There Were 19 Million New Cases Of Malignancy And Roughly 10 Million Cancer Re


Keywords

Dostarliamab Malignancy Colorectal Cancer Endometrial Cancer Immunotherapy T-Cells PD-1/PD-L1 Inhibitors Combination Therapy.

Paper ID

IJSARTV9I1274511

Publication Date

December 16, 2023

Research Area

Pharmaceutical Chemistry

Submit Your Paper to IJSART

Join the global research community with IJSART. Submit your paper, share your work, and gain worldwide recognition!